STAT3 and rheumatoid arthritis: In RA, cyanidin targets IL-17A/IL-17RA signaling, reducing fibroblast-like synoviocyte (FLS) proliferation, inflammatory markers (cyr61, IL-23, GM-CSF), and JAK/STAT-3 signaling, while activating PIAS3 to suppress STAT-3-driven inflammation.